✦ LIBER ✦

1214 DOSE-RELATED INCREASE IN VIROLOGIC RESPONSES USING CONTROLLED RELEASE NITAZOXANIDE PLUS PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4: FINAL REPORT

✍ Scribed by Keeffe, E.B.; Elfert, A.A.; Abousaif, S.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, P

✍ Shiffman, M.L.; Ahmed, A.; Jacobson, I.M.; Pruitt, R.E.; Keeffe, E.B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

OL-002 Effect of high-dose ribavirin (RB

✍ P.P. Basu; K. Rayapudi; T. Pacana; N.J. Shah; N. Krishnaswamy; H. Hampole; C. Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 224 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P1126 IMPACT OF SAFETY-RELATED DOSE REDU

✍ Foster, G.R.; Coppola, C.; Curescu, M.; Derbala, M.; Esmat, G.; Ferenci, P.; Fli 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

S1272 Effect of High-Dose Ribavirin (RBV

✍ P. Patrick Basu; Krishna Rayapudi; Tommy Pacana; Niraj James Shah; Nithya Krishn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB